infant probiotic drops BioGaia
Selected indexed studies
- Effect of Lactobacillus reuteri NCIMB 30351 drops on symptoms of infantile functional gastrointestinal disorders and gut microbiota in early infants: Results from a randomized, placebo-controlled clinical trial. (Eur J Pediatr, 2024) [PMID:38427038]
- Effects of Lactobacillus reuteri DSM 17938 in preterm infants: a double-blinded randomized controlled study. (Ital J Pediatr, 2019) [PMID:31706331]
- Effect of L. reuteri on bowel movements in children aged 6 months to 4 years: A double-blind randomized controlled trial. (Front Pediatr, 2022) [PMID:36389355]
_Worker-drafted node — pending editorial review._
Connections
infant probiotic drops BioGaia helps
Sources
- The early administration of Lactobacillus reuteri DSM 17938 controls regurgitation episodes in full-term breastfed infants. (2014) pubmed
- Preventive effects of oral probiotic on infantile colic: a prospective, randomised, blinded, controlled trial using Lactobacillus reuteri DSM 17938. (2015) pubmed
- Effect of Lactobacillus reuteri NCIMB 30351 drops on symptoms of infantile functional gastrointestinal disorders and gut microbiota in early infants: Results from a randomized, placebo-controlled clinical trial. (2024) pubmed
- Effects of Lactobacillus reuteri DSM 17938 in preterm infants: a double-blinded randomized controlled study. (2019) pubmed
- Effect of L. reuteri on bowel movements in children aged 6 months to 4 years: A double-blind randomized controlled trial. (2022) pubmed
- Efficacy of Limosilactobacillus reuteri UBLRu-87 in Infantile Colic and Its Symptoms: A Double-Blind, Placebo-Controlled Study. (2025) pubmed
- Lactobacillus Reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial. (2014) pubmed
- Effect of Lactobacillus reuteri LRE02-Lactobacillus rhamnosus LR04 combination and gastrointestinal functional disorders in an Emergency Department pediatric population. (2021) pubmed
- Limosilactobacillus reuteri ATCC PTA 5289 and DSM 17938 as adjuvants to improve evolution of pharyngitis/tonsillitis in children: randomised controlled trial. (2021) pubmed
- Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. (2013) pubmed